Clinical implication of 14-3-3 epsilon expression in gastric cancer

doi:10.3748/wjg.v18.i13.1531

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4546)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

412

HTML

3779

Figures (1-1)

184

Tables (1-1)

171

Sum=4546

Apr 7, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 7, 2012; 18(13): 1531-1537
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1531

Full Size Figure Download Figure

Figure 1 Expression of 14-3-3ε in tumor and non-neoplastic gastric tissue. A: Protein expression normalized by β-actin (ACTB); B: Ratio of protein expression between tumor and matched non-neoplastic gastric tissues; C: Western blotting using anti-14-3-3ε and anti-β-actin antibodies; D: mRNA expression normalized by the internal controls ACTB and glyceraldehyde-3-phosphate dehydrogenase; E: Relative mRNA quantification-gastric tumor samples normalized by matched non-neoplastic gastric tissues. T: Tumor samples; N: Non-neoplastic samples.

Citation: Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MAC. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol 2012; 18(13): 1531-1537
URL: https://www.wjgnet.com/1007-9327/full/v18/i13/1531.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i13.1531